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Abstract 
Background: Technology‑supported rehabilitation can help alleviate the increasing need for cost‑effective rehabili‑
tation of neurological conditions, but use in clinical practice remains limited. Agreement on a core set of reliable, valid 
and accessible outcome measures to assess rehabilitation outcomes is needed to generate strong evidence about 
effectiveness of rehabilitation approaches, including technologies. This paper collates and synthesizes a core set from 
multiple sources; combining existing evidence, clinical practice guidelines and expert consensus into European rec‑
ommendations for Clinical Assessment of Upper Limb In Neurorehabilitation (CAULIN).
Methods: Data from systematic reviews, clinical practice guidelines and expert consensus (Delphi methodology) 
were systematically extracted and synthesized using strength of evidence rating criteria, in addition to recommenda‑
tions on assessment procedures. Three sets were defined: a core set: strong evidence for validity, reliability, respon‑
siveness and clinical utility AND recommended by at least two sources; an extended set: strong evidence OR recom‑
mended by at least two sources and a supplementary set: some evidence OR recommended by at least one of the 
sources.
Results: In total, 12 measures (with primary focus on stroke) were included, encompassing body function and 
activity level of the International Classification of Functioning and Health. The core set recommended for clinical 
practice and research: Fugl‑Meyer Assessment of Upper Extremity (FMA‑UE) and Action Research Arm Test (ARAT); the 
extended set recommended for clinical practice and/or clinical research: kinematic measures, Box and Block Test (BBT), 
Chedoke Arm Hand Activity Inventory (CAHAI), Wolf Motor Function Test (WMFT), Nine Hole Peg Test (NHPT) and 
ABILHAND; the supplementary set recommended for research or specific occasions: Motricity Index (MI); Chedoke‑
McMaster Stroke Assessment (CMSA), Stroke Rehabilitation Assessment Movement (STREAM), Frenchay Arm Test (FAT), 
Motor Assessment Scale (MAS) and body‑worn movement sensors. Assessments should be conducted at pre‑defined 
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Background
Neurological conditions are a leading cause of disability 
world-wide. Incidence is rising due to an ageing world 
population and prevalence is increasing due to growth of 
the world population, better survival rates and improved 
long-term care [1]. The result is increasing pressure on 
the healthcare system globally and frames the need for 
effective and efficient approaches to enable and maintain 
access to care.
Recent advances in neurorehabilitation research have 
resulted in a better understanding of recovery, giving rise 
to new promising approaches such as increased intensity 
of practice, early intervention and use of technology. Of 
those, the use of technology in rehabilitation may help 
alleviate the pressure on the healthcare system. Moreo-
ver, technologies could enable access to rehabilitation 
throughout the lifespan and has been advocated by the 
World Health Organisation (WHO) as an investment in 
human capital that contributes to health, economic and 
social development [2].
For a successful transfer of therapeutic interventions 
using rehabilitation technology into clinical practice, evi-
dence of their effectiveness is essential. This is reflected 
in national strategies and frameworks emphasising the 
need for informed decision making in healthcare that is 
research-led and evidence-based. Yet, several national 
guidelines cite limited research evidence to justify the 
use of rehabilitation technologies [3–5]. Indeed, data on 
clinical evaluations of interventions in neurological reha-
bilitation, either conventional or technological, are not 
easily comparable due to inconsistency in what is actually 
measured [2], and the measurement tools used. Conse-
quently, there is a paucity of high-quality evidence from 
systematic reviews and meta-analyses [6].
Agreement on outcome measures (OM) and cor-
responding procedures for assessment are critical to 
advancing the field. For new approaches to be used effec-
tively in clinical practice (the right therapy approach with 
the right patients, at the right time and delivered via the 
most effective protocols), clinicians need clear assess-
ment guidelines to enable them to make informed deci-
sions. The use of agreed, uniform OM is not only useful 
in order to compare the effectiveness of different training 
approaches, but also to identify which patients benefit 
most from which training approach and dose.
For example, the use of different technologies for task-
oriented training of the upper limb was investigated in 
highly functional chronic stroke patients in two separate 
clinical trials using a sensor system [7] or a robot system 
[8]. As both studies used the same OM, results could be 
combined, showing that training with the inertial sensor 
system providing feedback on exercise performance was 
more beneficial for highly functional patients than the 
robot-guided system [9].
In addition, practical and accurate tools are emerging 
that can predict recovery, with the potential to signifi-
cantly improve patient management and reduce costs of 
health services [10]. Establishing and elaborating clinical 
prediction models for the upper limb, such as SAFE [11] 
and PREP2 [12], to facilitate personalisation of patient 
rehabilitation and discharge planning, can only occur 
if sufficient good quality objective assessment data is 
available.
The European Network on Robotics for Neuroreha-
bilitation (European Co-operation in Science and Tech-
nology, COST Action TD1006) has developed a set of 
recommendations for upper limb assessment in neu-
rological conditions, to evaluate both conventional and 
technology-supported therapy. These European recom-
mendations aim to improve the quality of upper limb 
neurorehabilitation in clinical practice globally, through 
the adoption of standardised, agreed protocols for assess-
ment in clinical practice and research. The recommenda-
tions will directly support clinical research and facilitate 
larger scale multi-centre studies, allowing meta-analyses, 
essential for informing and stimulating investigation of 
prediction for patient-specific training approaches and 
more generally advancing understanding of recovery. It 
will also inform and influence the development of new 
upper limb neurorehabilitation technologies both as 
therapies and assessment tools, and assist in the transla-
tion of useful technologies into clinical practice.
The present paper collates and synthesizes the recom-
mendations from multiple sources, combining existing 
regular intervals by trained personnel. Global measures should be applied within 24 h of hospital admission and 
upper limb specific measures within 1 week.
Conclusions: The CAULIN recommendations for outcome measures and assessment procedures provide a clear, sim‑
ple, evidence‑based three‑level structure for upper limb assessment in neurological rehabilitation. Widespread adop‑
tion and sustained use will improve quality of clinical practice and facilitate meta‑analysis, critical for the advancement 
of technology‑supported neurorehabilitation.
Keywords: Upper limb, Upper extremity, Assessment, Rehabilitation, Therapy, Outcome measures, Stroke, Traumatic 
brain injury, Spinal cord injury, Multiple sclerosis
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evidence, current clinical practice guidelines and expert 
consensus, into the recommendations for Clinical Assess-
ment of Upper Limb In Neurorehabilitation (CAULIN). 
The CAULIN recommendations provide evidence-based 
recommendations for upper limb assessment of patients 
with neurological conditions before, during and after 
therapy (either conventional or technology-assisted treat-
ment), including the recommended time frame of apply-
ing structured assessment where available.
Methods
Scope and purpose
The CAULIN recommendations were developed within 
the framework of a European network (COST  Action 
TD1006). This enabled involvement of more than 200 
experts and stakeholders from over 24 European coun-
tries, with a wide range of backgrounds: physical thera-
pists, occupational therapists, physicians and nurses 
(all working primarily in neurorehabilitation); clinical 
researchers from the same or related professions; engi-
neers, technology developers; neurological patients; and 
other stakeholders such as neurorehabilitation educators 
and healthcare insurers.
A systematic approach, in correspondence with the 
Appraisal of Guidelines for Research and Evaluation 
(AGREE) II methodology [13], addressing particularly 
the AGREE domains of scope and purpose, stakeholder 
involvement and rigour of development, was used. Both 
clinical and technology-generated outcome measures 
were considered, using an expanded version of the WHO 
International Classification of Functioning, Disability and 
Health (ICF) as the structuring model, distinguishing at 
the activity level between capacity (i.e., maximal ability 
measured in a controlled setting) and performance (i.e., 
level of functioning in a person’s current environment), 
with performance further divided between perceived 
(subjective experienced by a person) and actual (objec-
tively measured) performance. OM on participation level 
are not targeted specifically for the CAULIN recommen-
dations, considering that participation OM assess more 
complex activities and social life situations, which aren’t 
strongly related to UL functioning [14].
Although the evidence and information on which the 
recommendations are based focus primarily on stroke, 
other neurological conditions are addressed as well, 
including spinal cord injury (SCI), multiple sclerosis 
(MS), and traumatic brain injury (TBI). The recommen-
dations are primarily targeted at supporting clinicians 
during clinical decision making, but they are also appli-
cable to all professionals working in neurorehabilitation, 
including research, to establish uniform methods for 
reporting clinical outcomes.
Procedure for development of recommendations
A structured approach was applied to generate the rec-
ommendations, synthesizing three published sources 
of evidence: existing scientific literature, clinical prac-
tice guidelines and expert consensus (Fig.  1). Scientific 
evidence was provided by a systematic overview of sys-
tematic reviews on upper limb OM in stroke including 
evaluation of psychometric properties and clinical util-
ity [15]. An extensive survey of existing clinical practice 
guidelines provided recommendations and clinical evi-
dence on assessment and OM across different neurologi-
cal conditions [16]. Agreed expert opinions on use of OM 
for assessment of the upper limb in neurorehabilitation 
were derived from a Delphi consensus study among the 
24 European Union (EU) member countries of the COST 
Action, involving 60 clinicians, 35 clinical researchers, 77 
non-clinical researchers and 35 engineers [17]. Each of 
these research activities were coordinated and executed 
by members of the TD1006 COST Action (Working 
Group 1). These activities took largely place in parallel. 
With this paper we integrate their outcomes.
The CAULIN recommendations for upper limb assess-
ment in neurorehabilitation include:
(1) A recommendation on specific sets of OM on body 
functions and structures and activity level,
(2) A recommendation on assessment procedures 
specifying when, how and by whom the assess-
ments should be done.
Sources of information
Systematic reviews
The systematic overview of 13 systematic reviews (pub-
lished between 2004 and 2014) focused on the psycho-
metric properties and clinical utility of upper limb OM 
in stroke [15]. From 53 different upper limb OM included 
in the overview, 13 met the standards and criteria set for 
the validity, reliability, responsiveness and clinical utility. 
Of those, six OM demonstrated a high level of measure-
ment quality and clinical utility and were recommended 
for assessment of upper limb function and activity in 
research and clinical practice. All 13 OM with published 
evidence of adequate measurement quality (psychomet-
ric properties) and clinical utility were considered for the 
synthesized CAULIN recommendations.
Clinical practice guidelines
The evidence from 34 records (published between 2007 
and 2017), including existing national clinical guide-
lines and published practice guidelines, on assessment of 
upper limb in neurorehabilitation provided input from 
clinical practice to the CAULIN recommendations [16]. 
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The specific OM of body function, activity and participa-
tion recommended by these clinical practice guidelines 
for upper limb assessment were considered for the cur-
rent synthesis.
Expert consensus
A Delphi consensus exercise with six consensus rounds 
performed between 2011 and 2015 provided evidence 
from five expert groups, consisting of 208 clinicians and 
researchers from medical and engineering fields across 
Europe. In each expert group, votes were collected on 
questions and statements about the use of OM for upper 
limb assessment in neurorehabilitation. At least 69% con-
sensus was required for each statement to be included as 
a recommendation for the current synthesis [17].
Structured data synthesis
Recommended OM sets
Data from all three sources (systematic reviews, clinical 
practice guidelines, and expert consensus) were system-
atically extracted and combined to form specific sets of 
recommended OM (Fig. 1). The extracted data were syn-
thesized across the three sources by rating them, based 
on the strength of evidence, according to the following 
criteria:
• Core set (3-star rating): OM that demonstrated 
strong evidence for validity, reliability, responsiveness 
and clinical utility AND were recommended by at 
least two sources.
• Extended set (2-star rating): OM that demonstrated 
strong evidence for validity, reliability, responsiveness 
and clinical utility OR were recommended by at least 
two sources.
• Supplementary set (1-star rating): OM that showed 
some evidence for validity, reliability, responsiveness 
and clinical utility OR were recommended by at least 
one of the sources.
The core (3-star) and extended (2-star) sets of CAULIN 
recommended OM represent OM that are psychometri-
cally sound, have suitable clinical utility and have a solid 
support base in the clinical and research community. The 
core 3-star OM should, however, always be considered 
as a first choice for all clinical trials and implementa-
tion protocols in clinical settings. The 1-star rated OM 
represent those with good potential, but where the psy-
chometric properties, clinical utility or expert consensus 
is not fully established. These measures could be used 
where appropriate or for research purposes. For example, 
additional specific OM might be needed when investigat-
ing specific treatments, such as robot-assisted therapy or 
home-based therapy, or when patients present with spe-
cific problems or treatment goals.
Fig. 1 Schematic view of synthesis criteria for compiling CAULIN recommendations
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Assessment procedures
Two of the three sources, i.e., clinical practice guidelines 
and expert consensus, generated data on recommended 
procedures for assessment of upper limb functioning. 
Based on available information, data was extracted and 
categorized according to three characteristics: time spent 
in assessment; frequency and timing of assessments; per-
son who should conduct the assessments. Due to limited 
data available, rating of recommendations as done with 
OM selection couldn’t be applied to assessment proce-
dures, instead data synthesis consisted of summarizing 
and categorizing the evidence.
Results
Recommended OM
The synthesized results for the CAULIN recommenda-
tions on specific OM are shown in Table  1. A general 
recommendation concerning the scope of upper limb 
assessment has been highlighted across the three data 
sources: OM must be valid, reliable, responsive, clini-
cally available and useful, preferably a consolidated set. In 
total, 12 specific OM were included, covering body func-
tion and activity level of the ICF (Fig. 2).
The recommended core set (3-star rating) of OM for 
clinical practice consists of Fugl-Meyer Assessment 
of Upper Extremity (FMA-UE) and Action Research 
Arm Test (ARAT). These were the only two meas-
ures presenting good psychometric properties while 
being recommended in at least two of the three data 
sources (systematic reviews of OM and clinical practice 
guidelines).
The extended set (2-star rating) adds six more OM 
recommended for clinical practice and/or clinical 
research. Kinematic measures assessing movement qual-
ity and execution are recommended at body function 
level, although there isn’t sufficient information avail-
able in the examined sources to specify which kinematic 
variable(s) should be used (i.e., range of motion, smooth-
ness, etc.). Recommended OM to assess at activity level 
add four capacity measures with each a slightly different 
focus: Box and Block Test (BBT; timed unilateral gross 
motor dexterity), Chedoke Arm Hand Activity Inven-
tory (CAHAI; focusing on bilateral task execution), Wolf 
Motor Function Test (WMFT; uni- and bilateral timed 
performance and ability scoring), Nine Hole Peg Test 
(NHPT, timed unilateral fine motor dexterity); and the 
ABILHAND (patient-reported manual ability measure).
The supplementary set (1-star rating) includes addi-
tional OM that can be used for specific research pur-
poses. On body function level, the Motricity Index (MI), 
Chedoke-McMaster Stroke Assessment (CMSA) and 
Stroke Rehabilitation Assessment Movement (STREAM) 
are added. On activity level, the Frenchay Arm Test (FAT) 
and Motor Assessment Scale (MAS) are additional rec-
ommended OM to measure functional ability (activity 
capacity), as well as monitoring the amount of actual arm 
use in routine daily life (activity performance) through 
the use of body-worn movement sensors (e.g., acceler-
ometers, inertial measurement units—IMU).
Recommended assessment procedures
Although the extent of information available is limited 
on when and by whom assessments should be conducted, 
we have summarized the available evidence on assess-
ment procedures from the three published data sources 
(Table 2), as follows:
1. Assessments should be conducted at regular inter-
vals during rehabilitation at a minimum of four time 
points (early, 3-, 6- and 12-months after onset).
2. Global measures should be applied within 24  h of 
hospital admission and upper limb specific measures 
within 1 week.
3. During a rehabilitation program, assessment should 
be made at baseline (beginning of the program), 
interim (during the program), final (end of the pro-
gram), and follow-up (a set period of time after com-
pletion of the program).
4. Patients should always be assessed prior to discharge 
or transfer in order to support appropriate follow-up.
5. OM should be administered separately from treat-
ment, last no longer than three hours and be con-
ducted by healthcare professionals who are trained to 
use them.
Discussion
By combining existing evidence on OM from literature 
reviews, a systematic overview of national clinical prac-
tice guidelines across Europe and beyond, and expert 
consensus on a pan-European level, we compiled uni-
form and agreed evidence-based recommendations for 
Clinical Assessment of Upper Limb In Neurorehabilita-
tion (CAULIN). As such, CAULIN provides evidence-
based recommendations for upper limb assessment of 
patients with neurological conditions, primarily stroke, 
before, during and after therapy (either conventional 
or technology-assisted therapy), to be used primar-
ily in clinical applications, but also in clinical research. 
Furthermore, CAULIN defines the recommended time 
frame of applying structured assessment at four specific 
instances (early, 3, 6 and 12 months after admission). The 
CAULIN recommendations defined OM at three levels: 
core set (including 2 OM), extended set (adding 6 OM), 
and supplementary set (extending by 6 OM).
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Fig. 2 CAULIN recommendations for selected specific upper limb outcome measures in neurorehabilitation
Table 2 Recommendations for assessment procedures
Procedure Practice guidelines Expert consensus
Duration, 
frequency 
and timing of 
assessments
Stroke: Screen for impairment, activity limitations, participation 
restrictions, and environmental factors to direct treatment on 
admission and on transfer from hospital to community
Stroke: Assessment within 48 h including: function, safety, physi‑
cal readiness, and ability to learn and participate in rehabilitation
Stroke: Medical and global outcomes, impairment and activity 
early post stroke, at 3 months and ideally at 6 and 12‑months’ 
post stroke
Stroke: Early assessment and planning of discharge
Spinal Cord Injury: Pain, motor and sensory dysfunction assess‑
ment should be carried out within 24–48 h of admission and 
prior to discharge
Stroke: NIHSS performed by trained, certified assessors within 
the first 24 h, and consider re‑assessing prior to discharge from 
acute care
Stroke: Measure at predefined times to monitor recovery e.g., 
within one week of admission and discharge (or when transfer‑
ring care) end of the 1st week, 3rd and 6th month post‑stroke. 
Consider measures before each multidisciplinary meeting
Assessments should take no longer than three hours (92% agree‑
ment by clinicians)
Four face‑to‑face patient assessments per treatment programme: 
beginning, during and end, and at a set period of time after the 
end of the programme
Except for data collected automatically by technology (100% 
agreement for clinical practice)





Stroke: Clinicians should be trained in the use of measurement 
scales
Stroke: Healthcare professionals who have appropriate skills and 
training
Stroke: Assessment conducted by specialist staff
Stroke: Recommends multi‑disciplinary medical assessment
Multiple Sclerosis: Assessment should be conducted by a “health‑
care professional with appropriate expertise in rehabilitation and 
MS”
Stroke: Standardized rater training needs to be developed
Stroke: Multi‑disciplinary team assessment should be undertaken 
to establish the patient’s rehabilitation needs and goals
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The core set recommends FMA-UE and ARAT to 
be included as the core (3-star) assessments of upper 
limb function and activity capacity in clinical practice. 
This is in agreement with the consensus-based recom-
mendations of the Stroke Recovery and Rehabilitation 
Roundtable (SRRR) [18] and the results of a recent con-
sensus-based Delphi study [19]. The current outcome 
strengthens the recommendation of the use of FMA-UE 
and ARAT in routine clinical practice by collating evi-
dence, not only from consensus-based methods, but also 
from systematic reviews on existing literature and clinical 
practice guidelines. The global coverage of SRRR consen-
sus further supports the pan-European CAULIN core set 
recommendations for assessing upper limb function and 
capacity. Even though FMA-UE and ARAT assess upper 
limb functioning at different levels of the ICF framework 
and measure different constructs, strong correlations 
exist between both OM [20, 21]. It is recommended to 
apply both FMA-UE and ARAT whenever possible to 
cover both aspects of functioning. A choice for one over 
the other can however be based on the patient-specific 
treatment goals if needed (e.g., if administration time is 
limited).
The extended (2-star) set includes a mix of per-
formance-based and patient-reported OM (PROM), 
addressing both capacity and perceived performance of 
the arm in daily life. These assessments can be used as 
complementary assessments, depending on patient-spe-
cific treatment goals or needs in clinical practice, or on 
specific research objectives in clinical research. For exam-
ple, while the BBT and NHPT are easy to implement into 
clinical practice (i.e., they are short and quick to admin-
ister), they will provide summary information on task 
outcome. On the other hand, some of the other recom-
mended OM are more comprehensive and will take more 
time and training, while adding valuable information on 
task execution and strategies used by the patient. The 
CAULIN recommendations, however, emphasize that 
the core OM (FMA-UE and ARAT) should be prioritized 
over the extended and supplementary OM sets.
In addition, the CAULIN extended (2-star) set rec-
ommends kinematic measures for assessment of move-
ment quality on body function level. This extends the 
information gained through clinical assessments about 
task execution with more detailed information about its 
underlying aspects, for example movement smoothness 
[22]. This recommendation is primarily applicable for 
evaluation of specific, well-established tasks (e.g. reach-
ing or pointing) implemented in clinical practice or clini-
cal research. The use of kinematic measures has been 
encouraged to allow distinction between behavioural 
motor recovery and compensation [23, 24]. Furthermore, 
kinematic measures enable detection of more subtle and 
fine-grained changes and are thought to provide valuable 
information for individual treatment planning and evalu-
ation [25]. Similar to CAULIN recommendations, the 1st 
SRRR initiative could not recommend specific kinematic 
measures for clinical research [23]. A more recent 2nd 
SRRR initiative, however, did specify a set of consensus-
based kinematic measures for clinical research trials [6]. 
These guidelines propose kinematic data to be collected 
during two standardized movement tasks: a reaching task 
in the horizontal plane and a functional 3D reach-to-
grasp task, such as drinking from a glass [6].
The use of PROM is recommended in each of the three 
CAULIN sources for perceived activity performance, with 
the ABILHAND as the only specific tool demonstrating 
sufficiently strong psychometric properties and clinical 
utility. In line with the overall aim of rehabilitation, per-
ceived performance measures add valuable and necessary 
information about a person’s experienced limitations of 
upper limb use in daily life [26]. In the present synthesis, 
PROM were mentioned in all sources to deserve atten-
tion during UL assessment, but specific PROM’s besides 
ABILHAND couldn’t be extracted. Other OM exist that 
might be suitable (more detailed information is in the 
publications of the three data sources), but more effort to 
establish specific PROM guidelines is needed.
The evidence-base for assessments included in the 
supplementary (1-star) set is smaller compared to rec-
ommended 3- and 2-star OM. The additional OM in 
the supplementary set will primarily be applicable for 
clinical research or in specific contexts of clinical prac-
tice, depending on research questions or patient-specific 
treatment goals, as each of these assessments have their 
particular focus and advantages. One of the OM included 
in the supplementary set is sensor-based assessment 
of actual arm use in daily life. This adds the perspective 
of actual performance in ecologically valid real-life set-
tings to that of capacity measures, assessing the maxi-
mum score in a controlled setting, which are known to 
be incongruent [27]. Although a standardized way to 
implement sensor-based assessment of actual arm use as 
an activity performance measure couldn’t be established 
in the current work, studies have indicated that assessing 
the actual use of the affected arm in daily life with respect 
to the unaffected arm (using activity counts) provides 
insight in non-use of the affected arm and relates more 
to real-world arm use than functional outcome measures 
[28, 29]. Nevertheless, establishing the optimal way for 
application and analysis requires further research.
The use of goal attainment OM were mentioned in 
all three CAULIN sources, although no specific OM 
could be identified. Remarkably, a Cochrane review 
reported that only 3 out of 39 studies, investigating the 
effect of goal-setting on psychosocial outcomes during 
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rehabilitation of people with acquired disability, used a 
goal attainment evaluation [30]. Goal Attainment Scal-
ing was the only OM used in those studies. A clinical 
guideline on integrating goal setting into rehabilitation 
to inform individual treatment planning listed nine use-
ful goal attainment OM, but also wasn’t able to suggest a 
specific goal attainment OM [31]. Nevertheless, the cur-
rent findings underline that goal attainment OM should 
be considered in clinical practice and further research is 
needed to define suitable goal attainment OM.
In terms of assessment procedures, the current synthe-
sis derived the following recommendation: administra-
tion of upper limb specific OM should be done by trained 
healthcare professionals within 1  week of admission to 
rehabilitation and repeated prior to discharge or trans-
fer, with specific time points during rehabilitation (upon 
start, during, end of programme, with a follow-up assess-
ment). Despite the recognized importance of structured 
administration procedures, more specific recommen-
dations couldn’t be derived from the current synthesis. 
When considering only consensus-based evidence, spe-
cific advice on time points for clinical assessment has 
recently been proposed, with maximal 7 assessments 
across 12 months: within 3 days (OM at body functions 
level only), at day 7, at weeks 2, 4, 12, at 6 months, fol-
lowed by every 6th month [19]. These proposed time-
points are generally in alignment with the procedures 
recommended in CAULIN. Beyond this, more explicit 
recommendations on administration procedures beyond 
timing of assessment are desired for better comparability 
of outcomes.
Considerations and limitations
The current work has identified uniform and agreed OM 
for clinical assessment of upper limb with pan-European 
coverage, integrating evidence on psychometric proper-
ties with clinical practice guidelines and with evidence-
based consensus among clinicians, researchers and 
engineers, considering also clinical utility in aspects such 
as language availability, affordability and practical appli-
cability. Despite these strengths, several limitations and 
considerations should be noted.
Kinematic measures and sensor-based actual arm use 
are included in the current recommendations to quan-
tify movement quality and arm/hand use on body func-
tion and activity level, even though clinical applicability 
isn’t well-established yet. Such technology-supported 
assessments are increasingly used in research [32, 33], 
but they haven’t found their way to large scale applica-
tion in clinical practice. Current limitations are a lack of a 
standardized way to apply and analyse the data and miss-
ing information regarding its psychometric properties 
for the various scenarios [15, 34]. In case of kinematic 
assessment an additional, contemporary, limitation is 
the need for high-resolution, three-dimensional opto-
electronic systems [6], limiting application to special-
ized clinical centres that have access to such advanced 
systems and expertise required for the corresponding 
analysis. Apparently, the expected added value of objec-
tive measurement of upper limb function or actual use is 
compelling enough to have caught the attention of both 
researchers and healthcare professionals [17]. This is 
based on the rapid ongoing technological developments 
of equipment suitable for use outside of expert labs, such 
as accelerometers, inertial measurement units (IMU’s) 
or markerless video-based systems. Although currently 
regarded as not mature or user-friendly enough for rou-
tine use in clinical practice [6], it is expected that this 
will become possible in the coming years. This will then 
enable measurement of kinematic data and/or actual arm 
use in clinical settings during therapy, on the ward and 
even at home, without the need for advanced optoelec-
tronic systems. Based on the current synthesis, it is clear 
that this topic warrants further research.
Potential cultural differences that can influence the 
validity of task-based assessments (e.g., using cutlery) 
haven’t been directly addressed, even though language 
availability of OM has been considered. For example, for 
the FMA-UE official transcultural adaptations and vali-
dations are available [35–38]. Also, some of the clinical 
assessments that are part of the CAULIN recommenda-
tions are available in revised or shortened forms, opti-
mising administration time or psychometric properties 
[39–41], but this hasn’t been taken into consideration in 
this work.
Furthermore, the current synthesis shows that the 
majority of information about upper limb assessment 
deals with stroke. Nevertheless, wherever available, the 
CAULIN recommendations have used information on 
upper limb assessment from other populations. Based 
on available clinical practice guidelines, most informa-
tion besides stroke was available from TBI, followed by 
SCI and MS [16]. For MS, the OM in CAULIN recom-
mendations are in alignment with a previous review 
recommending amongst others NHPT, BBT, ARAT and 
WMFT as appropriate OM for MS [42]. Likewise, in SCI 
the ARAT has been used and recommended as primary 
upper limb functional outcome measure in clinical tri-
als [43, 44]. Therefore, although being represented to a 
smaller extent than the stroke population, available evi-
dence endorses the applicability of OM in the CAULIN 
recommendations for other neurological populations 
(TBI, SCI, MS), while considering the suitability of spe-
cific OM for the target population (e.g., FMA-UE would 
be applicable to TBI but not to SCI, ARAT is developed 
for stroke but is also used in SCI and MS).
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The current work showed that PROM, goal attain-
ment OM and sensor-based assessment of actual arm use 
in daily life are important concepts to include in upper 
limb assessment, although concrete recommendations 
based on consensus, clinical utility and psychometric 
properties, can’t be provided at this point. More research 
is needed to establish specific measures and/or meth-
ods. In addition, technological development is required 
to mature measurement systems and methods for use 
in clinical practice or research. This is also valid for kin-
ematic measures of movement quality, even though a 
basic application could be specified in the extended set 
of CAULIN recommendations. Increased availability of 
assessment of movement and task performance on ratio-
level, considering such developments in the (near) future, 
enables better detection of underlying, detailed changes. 
This will add valuable information for prognosis of recov-
ery and corresponding treatment planning on individual 
level, which can benefit the rehabilitation process [45].
It is, however, conceivable that any new or additional 
OM will meet the selection criteria as defined for the 
CAULIN recommendations at some point. Moreover, 
some of those new or additional measures could poten-
tially outperform some of the OM in the current selec-
tion, especially those with subjective (by the tester) and 
ordinal-level scoring involved. This entails that the rec-
ommendations should be updated in the future on a reg-
ular basis, to incorporate additional measures and revisit 
the selection of recommended OM, when these become 
available. Nevertheless, this means that the current CAU-
LIN recommendations are limited to OM currently avail-
able in clinical practice.
Conclusions
The CAULIN recommendations for OM and assessment 
procedures provide a clear, simple, evidence-based three-
level structure for upper limb assessment in neurological 
rehabilitation. OM in all three levels have proven psycho-
metric properties as well as evidence derived from sys-
tematic reviews and expert consensus. The three levels 
are: (1) Core set: OM that should be applied routinely 
in clinical practice with neurological patients undergo-
ing conventional or technology-enhanced upper limb 
rehabilitation; (2) Extended set: OM that may be useful 
in clinical practice but are recommended as standard 
for research, and (3) Supplementary set: OM for spe-
cific research purposes. The CAULIN recommendations 
provide a comprehensive framework, in the context of 
currently available OM, within which to investigate the 
effectiveness of (technology-supported) interventions 
and better understand which patients benefit from which 
training approach. This will facilitate treatment planning 
in clinical practice on patient-specific basis. Widespread 
adoption and sustained use of the recommendations 
will increase opportunities for data pooling and meta-
analysis, critical for the advancement of neurological 
rehabilitation.
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